Webcode 25032001
Dr Paul de Boissieu
Haute Autorité de Santé (HAS), FRANCE
Chair of the Joint Clinical Assessments subgroup. Paul de Boissieu is a senior assessor in solid oncology and haemato-oncology at the Drug Assessment Division of the French National Authority for Health (HAS). He is a medical doctor with a PhD in pharmacovigilance and pharmacoepidemiology.
Dr. Thomas Ecker
Ecker + Ecker GmbH and Accessus Health GmbH, GERMANY
CEO;
Thomas Ecker is CEO of Ecker + Ecker. Since 2004 he has focused on HTA, Pricing and Reimbursement of pharmaceuticals. In that role he has been responsible for more than 100 G-BA submissions and price negotiations. His current focus is on EU HTA strategy and dossier development.
More information please click here.
Alain Estival
Cemka, FRANCE
Co-Director Market Access
Christian Hill
MAP Patient Access, Cambridge, GREAT BRITAIN
Founder and Chief Strategy Officer; Christian is a seasoned Market Access professional with over 20 years of experience in the International Biotech and Pharmaceutical industry. He has been involved in over 50 HTAs across Europe and has built up a strong network of key influencers including EU and national agencies. Prior to co-founding MAP in 2012, he led market access teams and submissions at InterMune, Gilead, Pfizer and Genzyme on a very broad range of products and disease areas from chronic disease to ultra-orphan indications. Christian is a member of the Board of EUCOPE (European Confederation of Pharmaceutical Entrepreneurs); he is also a member of the Steering Group of EMIG (Ethical Medicines Industry Group) in the UK and Ireland.
Luis Lizán
Outcomes 10, SPAIN
CEO
Dr. Marco Penske
Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim
Head Market Access and Healthcare Affairs
Mariangela Prada
Intexo Società Benefit Srl, ITALY
CEO & Partner
Birgit Wolf
Bayer AG, Berlin
Global Regulatory Lead
24/03/2025
24/03/2025
9:00 am - 5:00 pm
online
online
Veranstaltung - 1,290 € zzgl. MwSt.
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.
Veranstaltung - 1,290 € zzgl. MwSt.
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.
Dr. Henriette Wolf-Klein
Head of Department
+49 6221 500-680
h.wolf-klein@forum-institut.de
Here you will get the latest information on the process of joint clinical assessments, including scoping and JCA dossier preparation.
This seminar helps you to prepare for EU HTA. It has a strong focus on the process of Joint Clinical Assessments, addressing the scoping process as well as the JCA dossier preparation.
After attending the seminar, you will be familiar with the new JCA process and know the commonalities and differences to national HTA dossiers in Germany, France, Italy, Spain, and the UK.
09:00 Introduction
09:15
Dr Paul de Boissieu
10:45 Coffee break
11:00
Birgit Wolf
11:50 Short break
12:00
Dr Thomas Ecker
12:45 Lunch break
13:45
Christian Hill, Alain Estival, Mariangela Prada, Luis Lizán
15:45 Coffee break
16:00
Dr. Marco Penske
17:00 End of the seminar
You need a reliable Internet connection to take part in our online events. To have the best possible learning experience, we recommend that you use the latest version of the Microsoft Edge or Google Chrome browsers. You will need a headset, loudspeaker or telephone to play the audio. Further information is available here. Please check beforehand that your microphone or headset and camera are working properly. Do not access our services from a VPN since there are issues with the audio over such connections.
We have integrated Zoom video conferencing software into our Learning Space for our online training courses. If you are not authorised to use Zoom, please get in touch with us so we can make alternative arrangements for you to take part in our online training.
of 5 stars of all ratings from 2023
of 5 stars on Trustpilot = good
Market Access ATMPs/Gentherapeutika - EU-HTA, Zugang zu Gentherapien, Integration eines ATMP in die GKV-Erstattung und v...
Dieser Workshop macht Sie fit für die G-BA Anhörung und vermittelt statistisches Know-how zur frühen Nutzenbewertung - ...
Hochwertiges e-Learning für Ihren fundierten und flexiblen Einstieg in das deutsche Gesundheitssystem.
Seminar zur Preisbildung, Abrechnung und Erstattung von Arzneimitteln in Deutschland
In diesem Seminar erfahren Sie alle Prozessschritte vom ersten Beratungsgespräch über die G-BA Entscheidung bis zum etwa...
